Events2Join

Patients taking edoxoban after heart valve surgery had lower risk of ...


Edoxaban Versus standard of care and their effects on clinical ...

Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: ...

Adverse Events Associated With the Addition of Aspirin to Direct Oral ...

Comparing 2 propensity score–matched groups of 1047 patients without a history of heart valve replacement or recent acute coronary syndrome, ...

NOACS or VKA in the elderly: can we find the antithrombotic sweet ...

In a post-hoc analysis of the ENVISAGE-TAVI AF trial (2), concomitant antiplatelet therapy was associated with an increased risk of bleeding ...

Dabigatran, Rivaroxaban, Edoxaban and Apixaban for AF

Patients with co-existing severe mitral valve disease/stenosis or mechanical heart valve ... surgery with risk of severe bleeding - defer and reassess risk post-.

Is There an Alternative Oral Anticoagulation to Vitamin-K ...

Factor Xa inhibitors were able to prevent thrombosis and thrombo-embolic events in patients after mechanical aortic valve replacement. Therefore ...

the-use-of-direct-oral-anticoagulants-in-patients-with-atrial ...

Patients who have had a bioprosthetic mitral valve replaced carry a greater thromboembolism risk ... edoxaban in patients early after surgical ...

ESC: Edoxaban Noninferior to Warfarin for Adverse Events After ...

Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–1331.

New Anticoagulants in Cardiac Surgery | ICR Journal

Rivaroxaban has a potential role in cardiac surgery as an adjunct to aspirin post-CABG, or as a replacement of VKAs in patients with mechanical ...

(PDF) Edoxaban for the Prevention of Thromboembolism in Patients ...

Patients with AF and bioprosthetic valves require anticoagulation to prevent thromboembolic events. Non-vitamin K oral anticoagulants (NOACs) are safe and ...

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ...

Patients with moderate to severe mitral stenosis or mechanical heart valves were excluded from the trial. Comparisons were made of rates of stroke/systemic ...

ACC.22: TAVI patients treated with edoxaban see fewer incidences ...

Prior studies also suggested that treatment with an anticoagulant rather than DAPT after TAVI might reduce patients' risk for a stroke or TIA.

Spironolactone, a blood pressure medication, may help reduce risk ...

Participants taking spironolactone (with or without colchicine) had a 31% lower risk of new or worsening heart failure than people taking ...

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and ...

In conclusion, DOACs are safe and effective in patients with atrial fibrillation and bioprosthetic valves. Future large-scale randomized studies are warranted ...

Summary of the Clinical Studies Reported in the European Society ...

The use of dabigatran in patients with mechanical heart valves was ... had lower MACE risk (0.63 [0.46–0.86]). Results were similar after excluding patients ...

Atrial fibrillation - Diagnosis and treatment - Mayo Clinic

Calcium channel blockers. These medicines control the heart rate but may need to be avoided by those who have heart failure or low blood ...

Irregular heartbeat after valve surgery increases risk of stroke, death

Postoperative atrial fibrillation, commonly known as Afib, has traditionally been viewed as benign and limited.

Direct Oral Anticoagulants: A Quick Guide - Expert Review - ISCP

... patients with mechanical heart valves taking dabigatran compared with warfarin patients. ... showed that the risk ... patients taking DOACs were less likely to view ...

Edoxaban not inferior to vitamin K antagonists after TAVR, but ...

They were randomized within seven days of TAVR and followed for a median of 554 days in the edoxaban group and 530 among the vitamin K ...

Eligibility Criteria Alphabetical Listing - Red Cross Blood Donation

... after a splenectomy or valvular heart disease. If you have a temperature above 99.5 F, you can not donate. Aspirin. Aspirin, no waiting period for donating ...

Roteas, INN-edoxaban

... heart valves, in patients ... lower risk of bleeding on edoxaban compared to warfarin (see section 4.4). ... After accounting for body weight, gender had no ...